The Locus Coeruleus, Norepinephrine and Cognitive Aging
NCT: NCT06880510 · ACTIVE_NOT_RECRUITING
Brief Summary
The locus coeruleus (LC) has recently been identified as one of the earliest sites of damage in AD with pathological lesions appearing as early as the mid-20s. In this study, the investigators use a variety of techniques including structural MRI, functional MRI, pupillometry, and transcutaneous vagus nerve stimulation to assess the health of the LC and its relation to easily measurable peripheral variables.
Frequently Asked Questions
What is The Locus Coeruleus, Norepinephrine and Cognitive Aging?
The Locus Coeruleus, Norepinephrine and Cognitive Aging is a clinical trial registered under NCT06880510. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06880510?
The current status of NCT06880510 (The Locus Coeruleus, Norepinephrine and Cognitive Aging) is: ACTIVE_NOT_RECRUITING.
When did The Locus Coeruleus, Norepinephrine and Cognitive Aging start?
The Locus Coeruleus, Norepinephrine and Cognitive Aging started on 2025-06-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.